Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age-Reference-Cited by-同舟云学术

Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age

Published:2016-02-17 Issue:3 Volume:33 Page:423-434
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Schwarz Hans-Peter,Walczak Mieczysław,Birkholz-Walerzak Dorota,Szalecki Mieczyslaw,Nanu Michaela,Woehling Heike,Schuck Ellen

Funder

Sandoz International GmbH

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-016-0301-1

Reference19 articles.

1. Omnitrope® European Public Assessment Report 2008. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000607/WC500043692.pdf . Accessed Feb 12, 2016.

2. Omnitrope® summary of product characteristics 2008. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000607/WC500043695.pdf . Accessed Feb 12, 2016.

3. Saenger P, Czernichow P, Hughes I, Reiter EO. Small for gestational age: short stature and beyond. Endocr Rev. 2007;28:219–51.

4. Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab. 2007;92:804–10.

5. Boguszewski MC, de Zegher F, Albertsson-Wikland K. Serum leptin in short children born small for gestational age: dose-dependent effect of growth hormone treatment. Horm Res. 2000;54:120–5.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IGF-1/IGFBP-3 Serum Ratio as a Robust Measure to Determine GH Deficiency and Guide Human Recombinant GH Therapy;The Journal of Clinical Endocrinology & Metabolism;2022-12-01

2. Growth hormone treatment does not to lead to insulin resistance nor excessive rise in IGF‐1 levels, while improving height in patients small for gestational age A long‐term observational study;Clinical Endocrinology;2021-12-09

3. Long-term follow up of carbohydrate metabolism and adverse events after termination of Omnitrope® treatment in children born small for gestational age;Therapeutic Advances in Endocrinology and Metabolism;2021-01

4. What is the evidence for beneficial effects of growth hormone treatment beyond height in short children born small for gestational age? A review of published literature;Journal of Pediatric Endocrinology and Metabolism;2019-12-20

5. Growth Hormone Disorders and Abnormal Stature in Kidney Disease;Endocrine Disorders in Kidney Disease;2019